Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 121762
Published online Dec 21, 2026. doi: 10.3748/wjg.121762
Published online Dec 21, 2026. doi: 10.3748/wjg.121762
Figure 3 The area under the curve values from the receiver operating characteristic analyses of the modified Clinical Outcomes of Ma lignant Biliary Obstruction-Biliary tract cancer Survival model, M stage, and carbohydrate antigen 19-9 level.
A: 3-month overall survival (OS) of the training group; B: 6-month OS of the training group; C: 1-year OS of the training group; D: 3-month OS of the validation group; E: 6-month OS of the validation group; F: 1-year OS of the validation group. The blue curve represented the modified Clinical Outcomes of Malignant Biliary Obstruction-Biliary tract cancer Survival model, the orange curve represented M stage, and the green curve represented carbohydrate antigen 19-9 level. AUC: Area under the curve.
- Citation: Zhang YZ, Tang YZ, Pan ST, He YX, Dai HC, Zhou WZ, Zhou HF. Survival prediction for patients with malignant biliary obstruction caused by biliary tract cancer undergoing percutaneous biliary decompression. World J Gastroenterol 2026; 32(47): 121762
- URL: https://www.wjgnet.com/1007-9327/full/v32/i47/121762.htm
- DOI: https://dx.doi.org/10.3748/wjg.121762